Evidence map

ReviewCancers2021

Glutamatergic Signaling a Therapeutic Vulnerability in Melanoma.

Kevinn Eddy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34359771